Hype or healing: unveiling the truth behind manuka honey?
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20233217Keywords:
MH, UMF, MGOAbstract
Aim of the study was to find out the effectiveness of Manuka honey (MH) in various applications to treat drug resistant ENT infections as an adjuvant therapy. The antibacterial properties and antioxidant properties of MH is attributed to the presence of high concentration of methylglyoxal (MGO) and flavonoid, phenolic compounds respectively. Unique manuka factor (UMF) rating is a scale used to determine the antibacterial potency of MH which directly correlates to the MGO and phenolic components in MH. Various cases of nasal crusting in post operative period with multidrug resistant bacterial cultures were included in the study. Each case was started on thorough nasal douching as well as manuka honey topical application. Regular and meticulous follow up was done for each case via endoscopic examination and medical record was kept of any potential side effects. Perichondritis of pinna was included in the study with potentially unique application the above-mentioned condition. MH is a natural antibiotic with low toxicity profile, allowing for prolonged use when necessary. Moreover, the development of bacterial resistance to honey has yet to be reported, making it an attractive alternative or adjunctive therapy, particularly in cases where antimicrobial resistance is a concern. While Manuka honey's antimicrobial properties have been observed in various studies, translating this knowledge into clinical practice requires rigorous investigation to ensure its effectiveness, safety, and proper integration with conventional antibiotic therapies.
Metrics
References
Antimicrobial Resistance Collaborators (ARC). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629‐55.
World Health Organisation. Antimicrobial resistance; Fact sheet. 2021. Available at: https://www.who.int/news‐room/fact‐sheets/detail/antimicrobial‐resistance. Accessed on 12 June, 2023.
Allen HK, Trachsel J, Looft T, Casey TA. Finding alternatives to antibiotics. Ann N Y Acad Sci. 2014;1323(1):91-100.
Hraiech S, Brégeon F, Rolain JM. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status. Drug Des Devel Ther. 2015;9:3653-63.
El-Senduny FF, Hegazi NM, Elghani GEA, Farag MA. Manuka honey, a unique mono-floral honey. A comprehensive review of its bioactives, metabolism, action mechanisms, and therapeutic merits. Food Bioscience. 2021;42:101038.
Ruiz-Argueso T, Rodriguez-Navarro A. Microbiology of ripening honey. Appl Microbiol. 1975;30(6):893-6.
Alvarez-Suarez J, Tulipani S, Romandini S, Bertoli E, Battino M. Contribution of honey in nutrition and human health: a review. Med J Nutrition Metab. 2010;3(1):15-23.
Mavric E, Wittmann S, Barth G, Henle T. Identification and quantifi¬cation of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res. 2008;52(4):483-9.
Weigel KU, Opitz T, Henle T. Studies on the occurrence and formation of 1,2-dicarbonyls in honey. Eur Food Res Technol. 2004;218(2):147-51.
Jenkins R, Cooper R. Improving antibiotic activity against wound pathogens with manuka honey in vitro. PLoS One. 2012;7(9):e45600.
Müller P, Alber DG, Turnbull L. Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS One. 2013;8(2):e57679.
Campeau ME, Patel R. Antibiofilm activity of Manuka honey in com¬bination with antibiotics. Int J Bacteriol. 2014;2014:1-7.
Theresa T. Honey as a Treatment in Otorhinolaryngology: A Review by Subspecialty. Ann Otol Rhinol Laryngol. 2019;128(3):193-207.
Sinead A. Inflammation and Endotyping in Chronic Rhinosinusitis-A Paradigm Shift. Medicina. 2019;55:95.
Rosenfeld RM, Andes D, Neil B, Cheung D, Eisenberg S, Ganiats TG et al. Clinical Practice Guideline: Adult sinusitis. Otolaryngol Head Neck Surg. 2007;137:S1-31.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. EPOS 2012: European Position Paper on Rhinosinusitis and Nasal Polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50:1-12.
Lane AP. The role of innate immunity in the pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2009;9(3):205-12.
Stella L. Chronic Rhinosinusitis as a Multifactorial Inflammatory Disorder. Curr Infect Dis Rep. 2011;13(2):159-68.
Cryer J, Schipor I, Perloff JR, Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec. 2004;66(3):155-8.
Psaltis AJ, Weitzel EK, Ha KR, Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol. 2008;22(1):1-6.
Singhal D, Psaltis AJ, Foreman A, Wormald PJ. The impact of biofilms on outcomes after endoscopic sinus surgery. Am J Rhinol Allergy. 2010; 24(3):169-74.
Jamil M. The association of Leptospermum honey with cytokine expression in the sinonasal epithelium of chronic rhinosinusitis patients. World J Otorhinolaryngol Head Neck Surg. 2018;5(1):19-25.
Cooper RA, Molan PC, Harding KG. The sensitivity to honey of gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol. 2002;93:857-63.
Kilty SJ, Duval M, Chan FT. Methylglyoxal: (active agent of manuka honey) in vitro activity against bacterial biofilms. Int Forum Allergy Rhinol. 2011;1:348-50.
Henriquez A, Jenkins R, Burton N. The intracellular effects of Manuka honey on Staphylococcus aureus. Eur J Clin Microbiol. 2010;29:45-50.
Jenkins R, Burton N, Cooper R. Manuka honey inhibits cell division in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2011;66(11):2536-42.
Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H et al. Diversity of TH Cytokine Profiles in Patients with Chronic Rhinosinusitis: A Multicenter Study in Europe, Asia, And Oceania. J Allergy Clin Immunol. 2016;138:1344-53.
Lu J, Carter D, Turnball L. The effect of New Zealand Kanuka, Manuka and clover honeys on bacterial growth dynamics and cellular morphology varies according to the species. PLoS One. 2013;8:e55898.
Müller P, Alber DG, Turnbull L. Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS One. 2013;8(2):e57679.
Jenkins RE, Cooper R. Synergy between oxacillin and manuka honey sensitizes methicillin-resistant Staphylococcus aureus to oxacillin. J Antimicrobial Chemotherapy. 2012;67(6):1405-7.
Fokkens WJ, Lund VJ, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;(23):31-298.
Rosenfeld RM, Andes D, Neil B, Cheung D, Eisenberg S, Ganiats TG et al. Clinical Practice Guideline: Adult sinusitis. Otolaryngol. Head Neck Surg. 2007;137:S1-31.
Jamil M, Andrew T. The association of leptospermm honey with cytokine expression in the sinonasal epithelium o chronic rhinosinsitis patients. World Otorhinolaryngol Head Neck Surg. 2019;5(1):19-25.
Almasadi A. Antimicrobial effect of different types of honey on S. aures. Saudi J Biological Sci. 2017;24(6):1255-61.
Camplin AL, Maddocks SE. Manuka honey treatment of biofilms of Pseudomonas aeruginosa results in the emergence of isolates with increased honey resistance. Ann Clin Microbiol Antimicrob. 2014;13:19.
Prasad HK, Sreedharan S, Prasad HS, Meyyappan MH, Harsha KS. Perichondritis of the auricle and its management. J Laryngol Otol. 2007;121(6):530-4.
Sosin M, Weissler JM, Pulcrano M, Rodriguez ED. Transcartilaginous ear piercing and infectious complications: a systematic review and critical analysis of outcomes. Laryngoscope. 2015;125(8):1827-34.
Henatsch D, Wesseling F, Briedé JJ, Stokroos RJ. Treatment of chronically infected open mastoid cavities with medical honey: a randomized controlled trial. Otol Neurotol. 2015;36(5):782-7.
